Stock Events

Stock Events

Aptorum Group 

$0.7057
49
-$6.35-90%Monday 01:08

Statistics

Day High
0.7074
Day Low
0.6717
52W High
1.24
52W Low
0.6717
Volume
309
Avg. Volume
-
Mkt Cap
574,704.44
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 20Expected
Q4 0
Q3 2025
Q3 2025
Q4 2025
Q2 2026
Next
0
0.01
0.02
0.02
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-4.27MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow APM.BOATS. It's not an investment recommendation.
NVIDIA
9
NVDA
Microsoft
8
MSFT
Apple
7
AAPL
Amazon
7
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences focuses on infectious diseases, a key area for Aptorum, making them direct competitors in developing treatments.
Merck
MRK
Mkt Cap368.89B
Merck operates in various therapeutic areas including infectious diseases, competing with Aptorum's research and development focus.
Pfizer
PFE
Mkt Cap173.95B
Pfizer has a broad portfolio including anti-infectives, directly competing with Aptorum's infectious disease projects.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie, with its research in diverse therapeutic areas, competes with Aptorum, especially in the infectious disease sector.
Novartis
NVS
Mkt Cap303.67B
Novartis competes across multiple therapeutic areas, including those targeted by Aptorum, making them a key competitor.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca has a strong focus on innovation in healthcare, including infectious diseases, positioning them as competitors to Aptorum.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb's diverse biopharmaceutical products compete with Aptorum's therapeutic development efforts.
AMGEN
AMGN
Mkt Cap251.94B
Amgen's broad focus on biotechnological medicines puts them in competition with Aptorum's diverse therapeutic pipeline.
Regeneron Pharmaceuticals
REGN
Mkt Cap95.99B
Regeneron Pharmaceuticals, known for its innovative treatments, competes with Aptorum in developing novel therapies.
Vertex Pharmaceuticals
VRTX
Mkt Cap141.65B
Vertex Pharmaceuticals' focus on creating transformative medicines for serious diseases competes with Aptorum's mission and pipeline.

About

Niki BioSolutions Inc is a clinical-stage life sciences company focused on unmet medical needs and providing genomic and biomarker testing solutions to healthcare providers, research institutions, and life sciences organizations. Its activities include the development and application of proprietary technologies to support precision medicine across therapeutic areas including brain health and oncology. The company also collaborates with academic centers, disease foundations, and biopharmaceutical companies.
Show More
CEO
ISIN
KYG6096M1226

Listings

STU
DE
APM.STU
MU
DE
APM.MU
XETRA
DE
APM.XETRA
XNAS
US
NIKI

0 Comments

Share your thoughts

FAQs

What is Aptorum Group stock price today?▼
The current price of APM.BOATS is $0.71 USD — it has decreased by -90% in the past 24 hours. Watch Aptorum Group stock price performance more closely on the chart.
What is Aptorum Group stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Aptorum Group stocks are traded under the ticker APM.BOATS.
What is Aptorum Group market cap?▼
Today Aptorum Group has the market capitalization of 574,704.44
When is the next Aptorum Group earnings date?▼
Aptorum Group is going to release the next earnings report on November 20, 2026.
What were Aptorum Group earnings last quarter?▼
APM.BOATS earnings for the last quarter are 0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Aptorum Group revenue for the last year?▼
Aptorum Group revenue for the last year amounts to 0 USD.
What is Aptorum Group net income for the last year?▼
APM.BOATS net income for the last year is -4.27M USD.
In which sector is Aptorum Group located?▼
Aptorum Group operates in the Other sector.
When did Aptorum Group complete a stock split?▼
The last stock split for Aptorum Group was on July 20, 2026 with a ratio of 1:10.